View of Revumenib: the newly approved food drug administration drug for the treatment of relapsed acute leukemia with a KMT2A translocation

Return to Article Details Revumenib: the newly approved food drug administration drug for the treatment of relapsed acute leukemia with a KMT2A translocation Download Download PDF